image
Healthcare - Biotechnology - NASDAQ - US
$ 5.71
3.45 %
$ 508 M
Market Cap
-7.49
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
584.50%
EBIT Estimate
--46.11%
Net Income Estimate
56.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets aTyr Pharma, Inc.
image
ATYR has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ATYR

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ATYR

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ATYR

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029